FUBP1 and osteosarcoma: The significant increases in IC50 values in FUBP1‐overexpressing osteosarcoma cells and decreases in IC50 values in FUBP1‐silenced cells versus control cells suggest that FUBP1 enhances the resistance of osteosarcoma cells to lobaplatin in vitro.